TARBP2 and adrenal cortex carcinoma: Moreover, in both cohorts, we confirmed the higher predictive values for TARBP2 when compared with DICER or DROSHA in the classification of ACC among adrenocortical tumors (Giordano et al.'s cohort: TARBP2, SEN=84%, SPE=100%; de Raynies et al.'s cohort: TARBP2, SEN=80%, SPE=82%).